Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission

A Cluster-randomized Controlled Trial of Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission

The purpose of this study is to evaluate the effectiveness of reducing HIV transmission among sero-discordant couples by applying comprehensive intervention components.

Study Overview

Status

Completed

Conditions

Detailed Description

A cluster-randomized controlled trial was carried out in forty counties from 16 cities. The strategy of Social Marketing was applied to influence sero-discordant couples' behavioral changes including safer sexual intercourses, regular HIV testing for the negative partners, antiretroviral therapy initiation.

Study Type

Interventional

Enrollment (Actual)

11096

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangxi
      • Nanning, Guilin, Laibin, Qinzhou, Guangxi, China, 530028
        • Center for Disease Control and Prevention,Guangxi Zhuang Autonomous Region
    • Henan
      • Zhumadian, Henan, China, 463000
        • Center for Disease Control and Prevention, Henan Province
    • Sichuan
      • Liangshan, Sichuan, China, 615000
        • Center for Disease Control and Prevention, Sichuan Province
    • Xinjiang
      • Urumchi, Ili, Xinjiang, China, 830002
        • Center for Disease Control and Prevention, Xinjiang Uygur Autonomous Region
    • Yunnan
      • Kunming, Dehong, Wenshan, Honghe, Yunnan, China, 650022
        • Center for Disease Control and Prevention, Yunnan Province

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 59 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Couples are required to have a stable relationship and live together in the last 3 months;
  • Older than 18 years and younger than 60 years; without regard to CD4 count;
  • Open cohort(any newly diagnosed serodiscordant couples who are eligible for treatment will be included during the study period).

Exclusion Criteria:

  • Couples are not have a stable relationship or do not live together in the last 3 months;
  • Younger than 18 years old.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
comprehensive intervention components
ART promotion, Couple testing and consulting promotion, and Condom use promotion
No Intervention: Usual
According the National HIV Antiretroviral treatment Guideline, provide treatment referrals for those treatment-eligible HIV-positive patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
HIV seroconversion rate of HIV negatives among HIV serodiscordant couples
Time Frame: up to 2 years
up to 2 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Proportion of HIV positives receiving ART among HIV serodiscordant couples
Time Frame: up to 2 years
up to 2 years
The incidence rate of AIDS-related diseases of HIV positives among serodiscordant couples
Time Frame: up to 2 years
up to 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Zuyou Wu, MD, PHD, National Center for AIDS/STD Control and Prevention, China CDC

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2012

Primary Completion (Actual)

December 31, 2015

Study Completion (Actual)

December 31, 2015

Study Registration Dates

First Submitted

December 26, 2012

First Submitted That Met QC Criteria

January 7, 2013

First Posted (Estimate)

January 9, 2013

Study Record Updates

Last Update Posted (Actual)

August 25, 2017

Last Update Submitted That Met QC Criteria

August 24, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 2012ZX10001007-001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV

Clinical Trials on comprehensive intervention components

3
Subscribe